Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Molecular Pharmacology
|
March 1, 1997
Extent and character of phenobarbital-mediated changes in gene expression in the liver
F W Frueh, U M Zanger, U A Meyer
Clinical Pharmacology and Therapeutics
|
August 24, 2007
The emerging role of pharmacogenomics in biologics
E Lacaná, S Amur, P Mummanneni, et al.
Clinical Pharmacology and Therapeutics
|
January 30, 2007
The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission program
M S Orr, F Goodsaid, S Amur, et al.
Toxicology Letters
|
August 8, 2001
Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression
F W Frueh, K C Hayashibara, P O Brown, et al.
The Pharmacogenomics Journal
|
July 26, 2005
The need for education in pharmacogenomics: a regulatory perspective
F W Frueh, F Goodsaid, A Rudman, et al.
The Pharmacogenomics Journal
|
March 29, 2006
Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop
F W Frueh, A Rudman, K Simon, et al.
Clinical Chemistry and Laboratory Medicine
|
May 16, 2003
Pharmacogenetics: from bench to bedside
H Erlich, J Bonnet, F W Frueh, et al.
The Pharmacogenomics Journal
|
August 28, 2013
Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial
S L Charland, B C Agatep, V Herrera, et al.
Clinical Pharmacology and Therapeutics
|
January 27, 2012
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey
E J Stanek, C L Sanders, K A Johansen Taber, et al.
Journal of the American Chemical Society
|
September 13, 2001
In situ synthesis of oligonucleotide arrays by using surface tension
J H Butler, M Cronin, K M Anderson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Molecular Pharmacology
|
March 1, 1997
Extent and character of phenobarbital-mediated changes in gene expression in the liver
F W Frueh, U M Zanger, U A Meyer
Clinical Pharmacology and Therapeutics
|
August 24, 2007
The emerging role of pharmacogenomics in biologics
E Lacaná, S Amur, P Mummanneni, et al.
Clinical Pharmacology and Therapeutics
|
January 30, 2007
The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission program
M S Orr, F Goodsaid, S Amur, et al.
Toxicology Letters
|
August 8, 2001
Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression
F W Frueh, K C Hayashibara, P O Brown, et al.
The Pharmacogenomics Journal
|
July 26, 2005
The need for education in pharmacogenomics: a regulatory perspective
F W Frueh, F Goodsaid, A Rudman, et al.
The Pharmacogenomics Journal
|
March 29, 2006
Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop
F W Frueh, A Rudman, K Simon, et al.
Clinical Chemistry and Laboratory Medicine
|
May 16, 2003
Pharmacogenetics: from bench to bedside
H Erlich, J Bonnet, F W Frueh, et al.
The Pharmacogenomics Journal
|
August 28, 2013
Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial
S L Charland, B C Agatep, V Herrera, et al.
Clinical Pharmacology and Therapeutics
|
January 27, 2012
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey
E J Stanek, C L Sanders, K A Johansen Taber, et al.
Journal of the American Chemical Society
|
September 13, 2001
In situ synthesis of oligonucleotide arrays by using surface tension
J H Butler, M Cronin, K M Anderson, et al.
Page
of 1